Inventor · disambiguated record
Céline Monnet
Also filed as: MONNET CELINE · MONNET CÉLINE
2 granted patents·8 pending applications·0 citations·filing 2015–2024
25Inventor score
Files withLAB FRANCAIS DU FRACTIONNEMENT8INST NAT SANTE RECH MED1LABORATOIRE FRANCAIS DU FRACTIIONNEMENT ET DES BIOTECHNOLOGIES1
Top patents by PatentIndex Score
10 records- 0168US2023265155A1Fc mutants with modified functional activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2023·Application pending·0 cites
- 0262US2025092150A1Fc polypeptide variants having an increased half-lifeLAB FRANCAIS DU FRACTIONNEMENT·Filed 2024·Application pending·0 cites
- 0351US11649271B2Fc mutants with modified functional activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Granted May 16, 2023·0 cites·24 claims
- 0446US2021214434A1Variants with fc fragment having an increased affinity for fcrn and an increased affinity for at least one receptor of the fc fragmentLAB FRANCAIS DU FRACTIONNEMENT·Filed 2018·Application pending·0 cites
- 0537US2019292269A1Fc polypeptide variants having an increased half-lifeLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Application pending·0 cites
- 0633US2021238281A1Highly sialylated autoantibodies and uses thereofINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0731US11814438B2Fc mutants with improved functional activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Granted Nov 14, 2023·0 cites·6 claims
- 0827US2020087394A1Antibodies targeting a ligand from an immune checkpoint, with an fc fragment having an improved affinity for cd16aLAB FRANCAIS DU FRACTIONNEMENT·Filed 2018·Application pending·0 cites
- 0926US2019218292A1Antibody for cancer treatmentLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Application pending·0 cites
- 1025US2017260254A1Method for producing variants having an fc with improved sialylationLABORATOIRE FRANCAIS DU FRACTIIONNEMENT ET DES BIOTECHNOLOGIES·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Céline Monnet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →